Analysis of alarming signals for the progression of atrophic gastritis to dysplasia

Revista Espanola de Enfermedades Digestivas

Volumn 104, Issue 8, 2012, Pages 399-404

  Zhang, Qiang ^a   Lian, Zhouyang ^b   Wang, Lei ^a   Wang, Yadong ^a   Zhi, Fachao ^a   An, Shengli ^c   Jiang, Bo ^a   Zhang, Yali ^a   Bai, Yang ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c Nanfang Medical University   (China)

Author keywords

Atrophic gastritis; Dysplasia; Follow up; Gastric ulcer; Helicobacter pylori

Indexed keywords

ADULT; ARTICLE; ATROPHIC GASTRITIS; ATROPHY; CHINA; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HELICOBACTER INFECTION; HIGH RISK PATIENT; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RETROSPECTIVE STUDY; STOMACH ULCER; SURVIVAL RATE;

EID: 84867258338     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/s1130-01082012000800002     Document Type: Article

References (23)

1. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945-52.
2. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: The Updated Sydney System. Am J Surg Pathol 1996;20: 1161-81.
3. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy, and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer, and early gastric cancer. World J Gastroenterol 2005;11:791-6.
4. Sauerbrei W. The use of resampling methods to simplify regression models in medical statistics. Appl Stat 1999;48:313-29.
5. Hsu CH, Long Q, Alberts DS. Estimation of colorectal adenoma recurrence with dependent censoring. BMC Med Res Method 2009;9:66.
6. Adamu MA, Weck MN, Rothenbacher D, Brenner H. Incidence and risk factors for the development of chronic atrophic gastritis: five year follow-up of a population-based cohort study. Int J Cancer 2011; 128:1652-8.
7. Weck MN, Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006;15:1083-94.
8. Gashi Z, Zekaj S, Haziri A, Bakalli A. The influence of the type of ulcers in the degree of atrophic gastritis. Med Arh 2011;65:20-2.
9. Silva S, Filipe MI, Pinho A. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut 1990;31:1097-104.
10. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JW. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002;50:378-81.
11. Lamarque D, Levy M, Chaumette MT, Roudot-Thoraval F, Cavicchi M, Auroux J, et al. Frequent and rapid progression of atrophy and intestinal metaplasia in gastric mucosa of patients with MALT lymphoma. Am J Gastroenterol 2006;101:1886-93.
12. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9.
13. Hodge DR, Hurt EM, Farrar WL. The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005;41:2502-12.
14. Nguyen T, Chai J, Li A, Akahoshi T, Tanigawa T, Tarnawski AS. Novel roles of local insulin-like growth factor-1 activation in gastric ulcer healing: promotes actin polymerization, cell proliferation, re-epithelialization, and induces cyclooxygenase-2 in a phosphatidylinositol 3- kinase-dependent manner. Am J Pathol 2007;170:1219-28.
15. Helander HF, Li H. Cell proliferation in the gastric epithelium of the ulcer rat. Scand J Gastroenterol 2005;40:1386-93.
16. Adamu MA, Weck MN, Gao L, Brenner H. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol 2010;25:439-48.
17. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China. A randomized controlled trial. JAMA 2004;291:187-94.
18. Yoo JY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Detection rate of Helicobacter pylori against a background of atrophic gastritis and/or intestinal metaplasia. J Clin Gastroenterol 2007;41:751-5.
19. Gonda TA, Tu S, Wang TC. Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 2009;8:2005-13.
20. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007;121:2381-6.
21. Kawanishi S, Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 2006;8:1047-58.
22. Katsurahara M, Kobayashi Y, Iwasa M, Ma N, Inoue H, Fujita N, et al. Reactive nitrogen species mediate DNA damage in Helicobacter pylori-infected gastric mucosa. Helicobacter 2009;14:552-8.
23. Konturek PC, Rembiasz K, Konturek SJ, Stachura J, Bielanski W, Galuschka K, et al. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci 2003;48:36-46.